Post Acute Analytics (“PAA”), the industry leader in intelligent care transition solutions, today announced the successful close of its latest funding round. The financing included participation from Humana and one other strategic investor, as well as existing investors, including Warburg Pincus, Dorilton Capital, and Generator Ventures.
This latest raise marks a major milestone in PAA’s mission to transform how patients transition across care settings. The capital will be used to accelerate growth of Anna™, PAA’s clinically intelligent proprietary platform, and to deepen the company’s partnerships across providers and payers, ultimately improving patient experience and lowering avoidable cost of care. This was a strong outcome for PAA shareholders and customers, ultimately allowing PAA to accelerate bringing to market solutions that benefit members with safer transitions, improved experience, and greater transparency of care.
“This raise is a strong validation of our strategy, technology, and colleagues,” said Saqib Akhter, CEO of Post Acute Analytics. “This investment underscores the real-world impact we’re delivering—empowering care teams with real-time insights, enabling safer patient transitions, and driving measurable value across the continuum.”
The newly secured funding will enable PAA to accelerate product development of Anna’s™ Clinically Intelligent Suite of Solutions, expand strategic payer and provider relationships, and scale real-time insights that enhance quality across the post-acute continuum.
This financing is a reflection of PAA’s leadership in transforming post-acute care and highlights strong investor confidence in PAA’s mission and team.
About Post Acute Analytics
Post Acute Analytics is a healthcare technology company redefining patient transitions through a connected, clinically intelligent platform. PAA’s solution provides real-time insights, predictive intelligence, and workflow automation to improve outcomes, reduce avoidable costs, and enhance transparency. Headquartered in Dallas, PAA partners with top health systems, national payers, and thousands of post-acute care providers across the U.S.
About Warburg Pincus
Warburg Pincus LLC is a leading global growth investor with more than $80 billion in assets under management. Its active portfolio includes over 245 companies in more than 40 countries. For more, visit www.warburgpincus.com.
About Dorilton Capital
Dorilton is a private investment firm that supports long-term growth across sectors, including healthcare and technology. Dorilton collaborates closely with management teams to build durable value. Learn more at www.doriltongroup.com.
About Generator Ventures
Generator Ventures is a purpose-driven investment platform focused on aging, senior care, and the intersection of health and technology. Generator partners with innovators advancing outcomes for older adults and caregivers. Learn more at https://generatorvc.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250915419196/en/
Contacts
Paul Martinchuk, CFO at (469) 444-7407
Domestic US: Irving, TX